Index RUT
P/E -
EPS (ttm) -0.56
Insider Own 54.21%
Shs Outstand 125.56M
Perf Week -6.52%
Market Cap 261.17M
Forward P/E -
EPS next Y -0.75
Insider Trans -0.12%
Shs Float 57.49M
Perf Month -14.05%
Income -70.21M
PEG -
EPS next Q -0.16
Inst Own 29.38%
Short Float 2.04%
Perf Quarter -23.81%
Sales 0.00M
P/S -
EPS this Y -17.65%
Inst Trans 0.72%
Short Ratio 10.99
Perf Half Y -26.24%
Book/sh 1.78
P/B 1.17
EPS next Y -24.67%
ROA -24.29%
Short Interest 1.17M
Perf Year -28.28%
Cash/sh 1.12
P/C 1.86
EPS next 5Y -
ROE -28.04%
52W Range 1.88 - 3.45
Perf YTD -30.43%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -27.97%
52W High -39.79%
Beta 0.97
Dividend TTM -
Quick Ratio 16.65
Sales past 5Y 0.00%
Gross Margin -
52W Low 10.93%
ATR (14) 0.16
Dividend Ex-Date -
Current Ratio 16.65
EPS Y/Y TTM -16.45%
Oper. Margin -
RSI (14) 39.55
Volatility 10.59% 6.98%
Employees 167
Debt/Eq 0.14
Sales Y/Y TTM -
Profit Margin -
Recom 2.60
Target Price 3.44
Option/Short Yes / Yes
LT Debt/Eq 0.12
EPS Q/Q -3.15%
Payout -
Rel Volume 0.80
Prev Close 2.11
Sales Surprise -
EPS Surprise 21.21%
Sales Q/Q -
Earnings Oct 29 BMO
Avg Volume 106.83K
Price 2.08
SMA20 -8.02%
SMA50 -17.95%
SMA200 -19.80%
Trades
Volume 85,993
Change -1.42%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-05-24 Downgrade
Goldman
Neutral → Sell
$1.75
Jun-27-24 Initiated
Guggenheim
Buy
$6
Jun-03-24 Resumed
Jefferies
Hold
$3
Jan-06-22 Initiated
Morgan Stanley
Equal-Weight
$8
Nov-02-21 Initiated
Cowen
Outperform
Aug-04-21 Initiated
Goldman
Neutral
$10
Jul-13-21 Initiated
Jefferies
Buy
$13
Oct-31-24 08:00AM
Oct-30-24 08:00AM
03:07AM
Oct-29-24 08:00AM
Oct-08-24 08:00AM
08:00AM
Loading…
Sep-17-24 08:00AM
Aug-14-24 08:00AM
Jul-30-24 08:00AM
Jul-09-24 08:00AM
May-23-24 08:00AM
May-03-24 12:00PM
May-01-24 11:11AM
03:08AM
Apr-30-24 11:54AM
08:00AM
07:36AM
Loading…
07:36AM
Apr-11-24 08:00AM
Feb-28-24 08:00AM
07:36AM
Feb-22-24 08:00AM
Feb-07-24 08:00AM
Nov-30-23 08:00AM
Nov-01-23 08:05AM
Oct-31-23 08:05AM
Oct-11-23 08:05AM
Sep-06-23 07:30AM
Aug-04-23 08:00AM
Aug-02-23 07:30AM
Jul-11-23 09:23AM
May-24-23 08:05AM
06:30AM
Loading…
May-02-23 06:30AM
Apr-18-23 04:05PM
Mar-23-23 08:00AM
Mar-07-23 08:00AM
Feb-23-23 06:05AM
Feb-21-23 08:00AM
Jan-26-23 08:00AM
07:45AM
Jan-19-23 08:00AM
Nov-16-22 08:00AM
Nov-01-22 06:05AM
Oct-05-22 08:00AM
Sep-23-22 08:00AM
Sep-01-22 08:00AM
Aug-30-22 08:00AM
Aug-11-22 06:30AM
Aug-02-22 06:48AM
Aug-01-22 04:05PM
Jul-13-22 08:00AM
May-12-22 06:28AM
May-03-22 06:00AM
Apr-12-22 08:00AM
Apr-07-22 08:00AM
Apr-04-22 08:00AM
Mar-31-22 04:05PM
Mar-05-22 07:22AM
Feb-24-22 06:00AM
Feb-16-22 04:05PM
Feb-02-22 01:38PM
Jan-27-22 08:00AM
Dec-16-21 01:07PM
(American City Business Journals)
Dec-05-21 06:39AM
Nov-02-21 08:00AM
06:00AM
Oct-11-21 08:00AM
Sep-10-21 10:21AM
Sep-03-21 09:00AM
Aug-10-21 06:00AM
Aug-09-21 08:00AM
Jul-13-21 08:00AM
Jun-17-21 07:00AM
Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MARY GODWIN Officer Dec 09 '24 Proposed Sale 2.13 35,000 74,588 Dec 09 04:28 PM MARY GODWIN Officer Dec 03 '24 Proposed Sale 2.20 60,000 131,778 Dec 03 04:28 PM MARY GODWIN Officer Nov 26 '24 Proposed Sale 2.28 60,000 136,512 Nov 26 04:31 PM MARY GODWIN Officer Nov 21 '24 Proposed Sale 2.35 30,000 70,623 Nov 21 05:28 PM MARY GODWIN Officer Nov 19 '24 Proposed Sale 2.27 30,000 68,046 Nov 19 05:00 PM MARY GODWIN Officer Nov 11 '24 Proposed Sale 2.47 40,000 98,884 Nov 12 11:38 AM MARY ELIZABETH GODWIN Officer Nov 08 '24 Proposed Sale 2.51 31,078 78,158 Nov 08 04:37 PM MARY ELIZABETH GODWIN Officer Nov 07 '24 Proposed Sale 2.75 28,922 79,643 Nov 07 04:25 PM Godwin Mary E. Senior VP, Operations Sep 23 '24 Option Exercise 0.46 47,031 21,634 47,031 Sep 25 06:29 PM Godwin Mary E. Senior VP, Operations Sep 23 '24 Sale 2.87 47,031 134,744 0 Sep 25 06:29 PM MARY ELIZABETH GODWIN Officer Sep 23 '24 Proposed Sale 2.86 47,031 134,739 Sep 23 04:58 PM Godwin Mary E. Senior VP, Operations Sep 17 '24 Option Exercise 0.46 35,000 16,100 35,000 Sep 18 06:32 PM Godwin Mary E. Senior VP, Operations Sep 17 '24 Sale 2.85 35,000 99,869 0 Sep 18 06:32 PM MARY ELIZABETH GODWIN Officer Sep 17 '24 Proposed Sale 2.85 35,000 99,866 Sep 17 04:22 PM Patel Sujal M CEO, President, and Secretary Mar 11 '24 Buy 2.84 12,044 34,216 10,064,488 Mar 11 08:21 PM Patel Sujal M CEO, President, and Secretary Mar 08 '24 Buy 2.99 2,430 7,262 10,052,444 Mar 11 08:21 PM Patel Sujal M CEO, President, and Secretary Mar 07 '24 Buy 2.89 18,854 54,424 10,050,014 Mar 07 07:06 PM Patel Sujal M CEO, President, and Secretary Mar 06 '24 Buy 2.70 9,267 25,034 10,031,160 Mar 07 07:06 PM Patel Sujal M CEO, President, and Secretary Mar 05 '24 Buy 2.65 7,405 19,597 10,021,893 Mar 07 07:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite